Literature DB >> 25531494

Serrated and non-serrated precursor lesions of colorectal cancer.

Cord Langner1.   

Abstract

Although often viewed as a single disease, colorectal cancer more accurately represents a family of diseases with different precursor lesions. Conventional (tubular, tubulovillous and villous) adenomas are the most common neoplastic lesions occurring in the large intestine. They have adenomatous polyposis coli (APC) mutations and arise from dysplastic aberrant crypt foci, initially as polyclonal lesions. In sporadic tumours, neoplastic progression follows the traditional pathway (chromosomal instability pathway), resulting in CpG island methylator phenotype (CIMP)-negative, microsatellite-stable (MSS), BRAF and KRAS wild-type cancers. Germline mutations in the APC gene lead to familial adenomatous polyposis. Conventional adenomas are also the precursors of Lynch syndrome-associated microsatellite-instable (MSI-high) cancers. Sessile serrated adenoma/polyp (SSA/P) is the principal precursor lesion of the serrated pathway, in which BRAF mutation can lead to colorectal cancer with MSI-high CIMP-high or MSS CIMP-high phenotype. SSA/Ps have been associated with synchronous and metachronous invasive adenocarcinomas as well as so-called interval carcinomas. Serrated polyposis is rare but most likely underdiagnosed. Affected individuals bear an increased but unspecified risk for the development of colorectal cancer; close endoscopic surveillance is warranted. Traditional serrated adenomas (TSAs) are much less common than the other serrated lesions. Cancers originating from TSAs may show KRAS mutation with a CIMP-high MSS phenotype.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25531494     DOI: 10.1159/000366032

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  15 in total

1.  Yogurt consumption and colorectal polyps.

Authors:  Samara B Rifkin; Francis M Giardiello; Xiangzhu Zhu; Linda M Hylind; Reid M Ness; Julia L Drewes; Harvey J Murff; Emma H Spence; Walter E Smalley; Joell J Gills; Gerard E Mullin; David Kafonek; Louis La Luna; Wei Zheng; Cynthia L Sears; Martha J Shrubsole
Journal:  Br J Nutr       Date:  2020-02-20       Impact factor: 3.718

2.  Silencing the GUCA2A-GUCY2C tumor suppressor axis in CIN, serrated, and MSI colorectal neoplasia.

Authors:  Babar Bashir; Dante J Merlino; Jeffrey A Rappaport; Esteban Gnass; Juan P Palazzo; Ying Feng; Eric R Fearon; Adam E Snook; Scott A Waldman
Journal:  Hum Pathol       Date:  2019-02-02       Impact factor: 3.466

3.  Genetic Mechanisms of Immune Evasion in Colorectal Cancer.

Authors:  Catherine S Grasso; Marios Giannakis; Daniel K Wells; Tsuyoshi Hamada; Xinmeng Jasmine Mu; Michael Quist; Jonathan A Nowak; Reiko Nishihara; Zhi Rong Qian; Kentaro Inamura; Teppei Morikawa; Katsuhiko Nosho; Gabriel Abril-Rodriguez; Charles Connolly; Helena Escuin-Ordinas; Milan S Geybels; William M Grady; Li Hsu; Siwen Hu-Lieskovan; Jeroen R Huyghe; Yeon Joo Kim; Paige Krystofinski; Mark D M Leiserson; Dennis J Montoya; Brian B Nadel; Matteo Pellegrini; Colin C Pritchard; Cristina Puig-Saus; Elleanor H Quist; Ben J Raphael; Stephen J Salipante; Daniel Sanghoon Shin; Eve Shinbrot; Brian Shirts; Sachet Shukla; Janet L Stanford; Wei Sun; Jennifer Tsoi; Alexander Upfill-Brown; David A Wheeler; Catherine J Wu; Ming Yu; Syed H Zaidi; Jesse M Zaretsky; Stacey B Gabriel; Eric S Lander; Levi A Garraway; Thomas J Hudson; Charles S Fuchs; Antoni Ribas; Shuji Ogino; Ulrike Peters
Journal:  Cancer Discov       Date:  2018-03-06       Impact factor: 39.397

Review 4.  K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Authors:  Nikolaos Margetis; Myrsini Kouloukoussa; Kyriaki Pavlou; Spyridon Vrakas; Theodoros Mariolis-Sapsakos
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

Review 5.  [Precursors of gastric cancer : Dysplasia and adenoma].

Authors:  C Langner
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

6.  Identification of key candidate genes and pathways associated with colorectal aberrant crypt foci-to-adenoma-to-carcinoma progression.

Authors:  Setareh Fayazfar; Afsaneh Arefi Oskouie; Akram Safaei; Hakimeh Zali; Ehsan Nazemalhosseini Mojarad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

7.  Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions.

Authors:  Chenghao Yi; Yanqing Huang; Xing Yu; Xiaofen Li; Shu Zheng; Kefeng Ding; Jinghong Xu
Journal:  Oncotarget       Date:  2016-03-29

8.  BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis.

Authors:  Naoya Sakamoto; Ying Feng; Carmine Stolfi; Yuki Kurosu; Maranne Green; Jeffry Lin; Megan E Green; Kazuhiro Sentani; Wataru Yasui; Martin McMahon; Karin M Hardiman; Jason R Spence; Nobukatsu Horita; Joel K Greenson; Rork Kuick; Kathleen R Cho; Eric R Fearon
Journal:  Elife       Date:  2017-01-10       Impact factor: 8.140

9.  The gut microbiota in conventional and serrated precursors of colorectal cancer.

Authors:  Brandilyn A Peters; Christine Dominianni; Jean A Shapiro; Timothy R Church; Jing Wu; George Miller; Elizabeth Yuen; Hal Freiman; Ian Lustbader; James Salik; Charles Friedlander; Richard B Hayes; Jiyoung Ahn
Journal:  Microbiome       Date:  2016-12-30       Impact factor: 14.650

Review 10.  What influences preneoplastic colorectal lesion recurrence?

Authors:  Giulia De Maio; Elisa Zama; Claudia Rengucci; Daniele Calistri
Journal:  Oncotarget       Date:  2017-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.